Executive Briefings | September 18, 2012
Personalized Medicine – Ready Or Not?
Tuesday, September 18, 2012
Personalized medicine is back in the news, including a new "pharmacogenetic test" for genetic markers to assess the effectiveness of antipsychotic drug treatments, SureGene and PGXL Laboratories launch the SureGene Test for Antipsychotic and Antidepressant Response, and the September 15 article in The New York Times – <a href="http://www.nytimes.com/2012/09/16/health/research/scientists-make-progress-in-tailor-made-organs . . .